Europlasma S.A. buy krebskrebs
Start price
25.01.21
/
50%
€18,400
Target price
25.01.22
€100,000
Performance (%)
-94.46%
End price
26.01.22
€1,020.0
Summary
This prediction ended on 26.01.22 with a price of €1,020.0. Massive losses of -94.46% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Europlasma S.A. | - | - | - | - |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % | 52,00 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % | 77,54 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % | 64,68 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % | 63,01 % |
Comments by krebskrebs for this prediction
In the thread Europlasma S.A. diskutieren
In the thread Trading Europlasma S.A.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten